Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...
Hoth Therapeutics Inc., a biopharmaceutical company committed to developing innovative therapies for unmet medical needs, has collaborated with OnTargetx R&D Inc. to accelerate research for its cancer ...
In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major ...
Finally, in the era of precision oncology, the FTD/TPI plus bevacizumab regimen can ... Pierre Fabre, Rottapharm, Takeda, and Tempus; invited speaker with compensation from Amgen, Bayer, Merck Serono, ...
Initially, Tempus AI's main initial focus has been on cancer research or oncology, where it has established business ties with roughly 2,500 institutions. According to its investor presentation ...
CK2 expression gastrointestinal cancer: Exploring clinical characteristics and cancer genetics. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...
From left to right: The 2025 home shirts of Super League clubs Hull KR, Leeds Rhinos, Hull FC and Castleford Tigers - Image Credits: Hull KR, Hull FC, OXEN Sports It’s that time of the year again when ...
Exploration of novel biomarkers and novel therapies for immune checkpoint inhibitors (ICIs) in genetic variants of esophageal squamous cell carcinoma (ESCC): A study of 1,059 Japanese cases.
Amid fresh controversy over the Board of Control for Cricket in India's alleged refusal to have 'Pakistan' printed on the team's Champions Trophy kits as part of the tournament logo, the Indian ...
Tempus AI shares surged more than 35% on Tuesday after former House Speaker Nancy Pelosi disclosed call options expiring in 2026. Several AI-related stocks are rising Wednesday after U.S ...
Toru Hanai / Bloomberg via Getty Images Shares of Tempus AI had their best day on record on Tuesday after the company launched an AI-powered health concierge. The stock also got a boost from ...